Citation: Bn. Cronstein et al., The vascular endothelium - A new actor in the pathogenesis of vascular injury in systemic lupus erythematosus, CONT IMMUN, 7, 1999, pp. 13-20
Citation: Hm. Belmont et al., Nitric oxide in systemic lupus erythematosus - Implications for immunity and inflammation, CONT IMMUN, 7, 1999, pp. 21-42
Citation: A. Perl et K. Banki, Molecular mimicry, altered apoptosis, and immunomodulation as mechanisms of viral pathogenesis in systemic lupus erythematosus, CONT IMMUN, 7, 1999, pp. 43-64
Citation: A. Rosen et L. Casciola-rosen, Clustering and proteolytic cleavage of autoantigens in surface blebs of apoptotic cells - Implications for pathogenesis of SLE, CONT IMMUN, 7, 1999, pp. 65-78
Citation: Iu. Khan et al., A genetic mechanism underlying deficient type I protein kinase A activity in systemic lupus erythematosus T lymphocytes, CONT IMMUN, 7, 1999, pp. 257-277
Authors:
Horwitz, DA
Gray, JD
Ohtsuka, K
Toro, B
Stimmler, MM
Hsu, L
Citation: Da. Horwitz et al., Natural killer cells and CD8(+) T cells in the downregulation of antibody production in healthy subjects and SLE - A role for transforming growth factor-beta and interleukin-2, CONT IMMUN, 7, 1999, pp. 312-320
Citation: D. Verthelyi et Dm. Klinman, Balance between type 1 and type 2 cytokine-secreting cells - Impact on disease activity in systemic lupus erythematosus, CONT IMMUN, 7, 1999, pp. 361-370
Citation: M. Reichlin, Autoantibodies to intracellular antigens in systemic lupus erythematosus patients that bind and penetrate cells, CONT IMMUN, 7, 1999, pp. 389-398
Citation: M. Satoh et al., Pathogenesis of autoantibody production and glomerulonephritis in pristane-treated mice - An inducible model of SLE, CONT IMMUN, 7, 1999, pp. 399-416